131 related articles for article (PubMed ID: 12875921)
1. Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans.
Itokawa M; Arai M; Kato S; Ogata Y; Furukawa A; Haga S; Ujike H; Sora I; Ikeda K; Yoshikawa T
Neurosci Lett; 2003 Aug; 347(3):202-4. PubMed ID: 12875921
[TBL] [Abstract][Full Text] [Related]
2. No association between a functional polymorphism in the promoter region of the neuropeptide Y gene (-485C>T) and schizophrenia.
Inoue Y; Shinkai T; Utsunomiya K; Sakata S; Fukunaka Y; Yamaguchi W; Yamada K; Chen HI; Hwang R; Ohmori O; Nakamura J
Neurosci Lett; 2009 Mar; 452(1):72-4. PubMed ID: 19150389
[TBL] [Abstract][Full Text] [Related]
3. Association study of two functional single nucleotide polymorphisms of neuropeptide y gene with multiple sclerosis.
Mohammadi SM; Shirvani Farsani Z; Dosti R; Sahraian MA; Behmanesh M
Neuropeptides; 2016 Dec; 60():45-50. PubMed ID: 27559040
[TBL] [Abstract][Full Text] [Related]
4. [Association study between NPY and YWHAH gene polymorphisms and schizophrenia].
Wang HS; Duan SW; Xing QH; Du J; Li XW; Xu YF; Zhang ZZ; Wang YJ; Feng GY; He L
Yi Chuan Xue Bao; 2005 Dec; 32(12):1235-40. PubMed ID: 16459651
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses.
Zhang K; Rao F; Miramontes-Gonzalez JP; Hightower CM; Vaught B; Chen Y; Greenwood TA; Schork AJ; Wang L; Mahata M; Stridsberg M; Khandrika S; Biswas N; Fung MM; Waalen J; Middelberg RP; Heath AC; Montgomery GW; Martin NG; Whitfield JB; Baker DG; Schork NJ; Nievergelt CM; O'Connor DT
J Am Coll Cardiol; 2012 Oct; 60(17):1678-89. PubMed ID: 23021333
[TBL] [Abstract][Full Text] [Related]
6. Association of the C-399T promoter polymorphism of neuropeptide Y with susceptibility to ischemic stroke.
Kim NS; Oh SM; Ko MM; Cha MH; Kang BK; Bang OS
Clin Biochem; 2009 Nov; 42(16-17):1699-704. PubMed ID: 19619519
[TBL] [Abstract][Full Text] [Related]
7. A family-based association study of schizophrenia with polymorphisms at three candidate genes.
Duan S; Gao R; Xing Q; Du J; Liu Z; Chen Q; Wang H; Feng G; He L
Neurosci Lett; 2005 Apr; 379(1):32-6. PubMed ID: 15814194
[TBL] [Abstract][Full Text] [Related]
8. Association study of arcuate nucleus neuropeptide Y neuron receptor gene variation and serum NPY levels in clozapine treated patients with schizophrenia.
Klemettilä JP; Kampman O; Solismaa A; Lyytikäinen LP; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Mononen N; Lehtimäki T; Leinonen E
Eur Psychiatry; 2017 Feb; 40():13-19. PubMed ID: 27837667
[TBL] [Abstract][Full Text] [Related]
9. Functional characterisation of the bovine neuropeptide Y gene promoter and evaluation of the transcriptional activities of promoter haplotypes.
Alam T; Bahar B; Waters SM; McGee M; O'Doherty JV; Sweeney T
Mol Biol Rep; 2012 Feb; 39(2):919-28. PubMed ID: 21562764
[TBL] [Abstract][Full Text] [Related]
10. Association of Neuropeptide-Y (NPY) and Interleukin-1beta (IL1B), Genotype-Phenotype Correlation and Plasma Lipids with Type-II Diabetes.
Patel R; Dwivedi M; Mansuri MS; Ansarullah ; Laddha NC; Thakker A; Ramachandran AV; Begum R
PLoS One; 2016; 11(10):e0164437. PubMed ID: 27749914
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y gene polymorphism and plasma neuropeptide Y level in febrile seizure patients in Taiwan.
Lin LC; Lin HS; Yang RC
Kaohsiung J Med Sci; 2007 Nov; 23(11):560-5. PubMed ID: 18055304
[TBL] [Abstract][Full Text] [Related]
12. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.
Heilig M; Zachrisson O; Thorsell A; Ehnvall A; Mottagui-Tabar S; Sjögren M; Asberg M; Ekman R; Wahlestedt C; Agren H
J Psychiatr Res; 2004; 38(2):113-21. PubMed ID: 14757324
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma.
Skibola DR; Smith MT; Bracci PM; Hubbard AE; Agana L; Chi S; Holly EA
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1251-6. PubMed ID: 15894681
[TBL] [Abstract][Full Text] [Related]
14. Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence.
Okahisa Y; Ujike H; Kotaka T; Morita Y; Kodama M; Inada T; Yamada M; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
Psychiatry Clin Neurosci; 2009 Jun; 63(3):417-22. PubMed ID: 19566775
[TBL] [Abstract][Full Text] [Related]
15. No association between the -399 C > T polymorphism of the neuropeptide Y gene and schizophrenia, unipolar depression or panic disorder in a Danish population.
Lindberg C; Koefoed P; Hansen ES; Bolwig TG; Rehfeld JF; Mellerup E; Jørgensen OS; Kessing LV; Werge T; Haugbøl S; Wang AG; Woldbye DP
Acta Psychiatr Scand; 2006 Jan; 113(1):54-8. PubMed ID: 16390370
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis.
Shah SH; Freedman NJ; Zhang L; Crosslin DR; Stone DH; Haynes C; Johnson J; Nelson S; Wang L; Connelly JJ; Muehlbauer M; Ginsburg GS; Crossman DC; Jones CJ; Vance J; Sketch MH; Granger CB; Newgard CB; Gregory SG; Goldschmidt-Clermont PJ; Kraus WE; Hauser ER
PLoS Genet; 2009 Jan; 5(1):e1000318. PubMed ID: 19119412
[TBL] [Abstract][Full Text] [Related]
17. Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect.
Sommer WH; Lidström J; Sun H; Passer D; Eskay R; Parker SC; Witt SH; Zimmermann US; Nieratschker V; Rietschel M; Margulies EH; Palkovits M; Laucht M; Heilig M
Hum Mutat; 2010 Aug; 31(8):E1594-608. PubMed ID: 20648632
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y genes and suicidal behaviour among schizophrenic patients.
Wang AG; Koefoed P; Jacoby AS; Woldbye D; Rasmussen HB; Timm S; Dam H; Jakobsen KD; Nordentoft M; Jürgens G; Sorensen HJ; Garsdal O; Hvid M; Werge T
Psychiatr Genet; 2013 Jun; 23(3):139-40. PubMed ID: 23407263
[No Abstract] [Full Text] [Related]
19. Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients.
Testa A; Mallamaci F; Macrì R; Pisano A; Spoto B; Malatino LS; Stancanelli B; Tripepi G; Benedetto FA; Zoccali C
J Hypertens; 2010 Aug; 28(8):1745-51. PubMed ID: 20543711
[TBL] [Abstract][Full Text] [Related]
20. [Relationship Between Alcohol Dependence and Neuropeptide Y (NPY) Gene Promoter Polymorphisms in A Turkish Sample].
Akel Bilgiç H; Gürel ŞC; Ayhan Y; Karahan S; Karakaya İ; Babaoğlu M; Dilbaz N; Uluğ BD; Demir B; Karaaslan Ç
Turk Psikiyatri Derg; 2020; 31(4):232-238. PubMed ID: 33454934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
